Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 28, 2012
Patent Application Number
13155909
Date Filed
June 8, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to chimeric immune receptor molecules for reducing or eliminating tumors. The chimeric receptors are composed a C-type lectin-like natural killer cell receptor, or a protein associated therewith, fused to an immune signaling receptor containing an immunoreceptor tyrosine-based activation motif. Methods for using the chimeric receptors are further provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
